Tryptamine Therapeutics ( (AU:TYP) ) has issued an update.
Tryptamine Therapeutics Limited has announced the quotation of 162,500,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of March 31, 2025. This move is part of previously announced transactions, potentially impacting the company’s market presence and providing stakeholders with increased liquidity and investment opportunities.
More about Tryptamine Therapeutics
Tryptamine Therapeutics Limited operates in the pharmaceutical industry, focusing on the development and commercialization of therapeutic products.
YTD Price Performance: -15.79%
Average Trading Volume: 1,658,752
Technical Sentiment Signal: Buy
Current Market Cap: A$40.85M
For a thorough assessment of TYP stock, go to TipRanks’ Stock Analysis page.